– CANADA, Mississauga – MedAvail Holdings, Inc. (Nasdaq: MDVL), a technology-enabled pharmacy company, today announced the appointment of Dr. Mark Doerr (RPh) to its Board of Directors as CEO, effective January 10, 2022, succeeding Ed Kilroy, who retired from the company.
Concurrently, the company also announced the appointments of Laurie McGraw and Paul Johnson to its Board of Directors effective January 10, 2022, while current Board member, Rob Faulkner became Chairman of the Board succeeding Gerard van Hamel Platerink who has stepped down as chairperson.
Helen Ciesielski, who has served on the board of directors since 2018, also stepped down.
“The Board and I are very pleased that Mark will be leading MedAvail forward. He brings almost 30 years of experience in building and scaling organizations in pharmacy technology services. As MedAvail enters its next phase of growth, we are confident that Mark is the right strategic leader to drive value for MedAvail stakeholders.” said Board Chairman, Rob Faulkner.
New CEO, Dr. Mark Doerr added, “I am also thrilled to welcome healthcare industry leaders, Laurie and Paul, to our board. They will be extremely valuable as we advance our initiatives to accelerate sustainable growth for MedAvail. I look forward to working alongside our management team and our board members, as we execute our strategy and deliver on our large growth opportunities ahead.”
About Mark Doerr
Mr. Doerr has nearly 30 years of leadership experience in pharmacy services. Before MedAvail, he was SVP and General Manager at Change Healthcare for its Pharmacy Business Unit where he was responsible for all pharmacy business lines and led a 400-member team. Before Change Healthcare, Mr. Doerr served as CEO of the Blackstone-owned eRx Network that he successfully grew and which was acquired by Change Healthcare. He also served as SVP of Pharmacy at Giant Eagle. Earlier in his career, Mr. Doerr held key leadership roles with Adheris Health, Catalina Health, and Sears Health.
“I am honored to be joining MedAvail as CEO. This is an exciting time for MedAvail. Our technology solutions are unmatched, and we are uniquely positioned to provide transformative pharmacy technology and services that can truly benefit the lives of patients. We have an exciting pathway to accelerate the expansion of our pharmacy solutions.” commented Mr. Doerr.
Mr. Doerr holds a Bachelor of Science in Pharmacy from Ohio Northern University.
About Laurie McGraw
Ms. McGraw is currently SVP, Health Solutions, a division of the American Medical Associations, where she is responsible for AMA’s data solutions used for innovation and standard-setting across the entire healthcare industry, which is a position she has held since February 2016. From 2013 to 2015, Ms. McGraw served as CEO of Shareable Ink, a clinical documentation and data solutions company. From 2000 to 2013, Ms. McGraw served in various leadership roles at Allscripts including President, Enterprise Solutions, and Chief Client Officer. Ms. McGraw also spent ten years as a development leader and head of client success at ChannelHealth/IDX before its sale to Allscripts.
Ms. McGraw received an Sc. B. with honors from Brown University.
About Paul Johnson
Mr. Johnson is currently VP, General Manager, Consumer of 23andMe Holding Co. (Nasdaq: ME), a leading consumer genetics and research company, a position he has held since November 2021. From November 2013 until November 2021, Mr. Johnson served in various roles at Lemonaid Health, an online health company, before its acquisition by 23andMe, including as CEO from February 2018 until November 2021, Co-CEO from June 2015 until February 2018, and COO from November 2013 until June 2015. In this capacity, Mr. Johnson developed and oversaw the company’s growth and exit. Before Lemonaid Health, he held roles as Head of Online at Lloyds Pharmacy and Director, UK at Zooplus AG.
Mr. Johnson holds a Bachelor of Science, with honors in IT and Business Management from the University of Worcester.
About MedAvail
MedAvail Holdings, Inc. is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes.
For more information: https://medavail.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
